Viewing StudyNCT05618301



Ignite Creation Date: 2024-05-06 @ 6:18 PM
Last Modification Date: 2024-10-26 @ 2:45 PM
Study NCT ID: NCT05618301
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2022-11-08

Brief Title: Motixafortide and Natalizumab to Mobilize CD34 Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease SCD
Sponsor:
Organization: Washington University School of Medicine